Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peribulbar Block in Strabismus Surgery
NCT04549844Phase 4Unknown
- Sponsor
- Fayoum University Hospital
- Start
- Aug 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of bupivacaine hydrochloride 0.75% injection in strabismus, sponsored by Fayoum University Hospital. Primary endpoint: Incidence of Oculocardiac reflex at 3 months. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
strabismus
Beyond the preview
Go deeper on NCT04549844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04549844.